Novel Combination of Cyclooxygenase-2 and MEK Inhibitors in Human Hepatocellular Carcinoma Provides a Synergistic Increase in Apoptosis

This publication has 10 references indexed in Scilit:

• Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells
  Hepatology, 2002
• Expression of survivin during liver regeneration
  Biochemical and Biophysical Research Communications, 2002
• NS‐398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines
  International Journal of Cancer, 2002
• Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide
  Carcinogenesis: Integrative Cancer Research, 2002
• Expression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
  Hepatology, 2001
• Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
  2001
• Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
  2001
• Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway
  Oncogene, 1999
• Regulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
  Journal of Biological Chemistry, 1999
• Rising Incidence of Hepatocellular Carcinoma in the United States
  New England Journal of Medicine, 1999